Compounds > edatrexate
Page last updated: 2024-08-23

edatrexate and Malignant Melanoma

edatrexate has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodurtha, AJ; Davidson, J; Eisenhauer, EA; Iscoe, NA; Quirt, IC; Verma, S; Young, VJ1
Gandara, DR; Kuriakose, P; Perez, EA1

Trials

2 trial(s) available for edatrexate and Malignant Melanoma

ArticleYear
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:3

    Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Canada; Drug Administration Schedule; Humans; Melanoma; Middle Aged

1993
Phase I trial of edatrexate in advanced breast and other cancers.
    Cancer investigation, 2002, Volume: 20, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Lung Neoplasms; Maximum Tolerated Dose; Melanoma; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome

2002